Abstract. Background: Gestational diabetes mellitus (GDM) and low magnesium (Mg) intake and status are associated with an increased risk of type 2 diabetes. However, Mg homeostasis may be modified by GDM. We sought to determine if a history of GDM prospectively modifies associations between Mg and glycemic variables in mothers and their offspring. Methods: Plasma and dietary Mg, anthropometric, lifestyle and glycemic variables were assessed in mothers affected by GDM during 1989-1990, a comparative group of normoglycemic women, pregnant during the same time period, and the 15-year-old, nondiabetic daughters of affected and unaffected pregnancies (n = 332). Multivariate regression analyses evaluated the cross-sectional association between plasma and dietary Mg with glycemic variables in mothers and daughters. Results: Plasma Mg was lower in mothers with a history of GDM in comparison to control mothers after adjustment for current type 2 diabetes, race and body mass index (0.90 ± 0.01 versus 0.96 ± 0.01 mmol/L; p = 0.002). Plasma Mg was significantly associated with insulin sensitivity and was inversely associated with fasting insulin in GDM mothers only (p<0.05). Plasma and dietary Mg were significantly inversely associated with glycated hemoglobin and fasting glucose, respectively, in nondiabetic teenage daughters. For fasting glucose, plasma Mg was inversely associated in GDM-born daughters only. Conclusions: Associations between plasma Mg and some glycemic variables may be stronger in mothers and offspring with a history of GDM.
rate-limiting enzymes of glycolysis, playing a critical regulatory role in phosphorylation reactions, such as tyrosine-kinase phosphorylation of the insulin receptor [3] . Significant inverse associations between serum Mg [4] , dietary Mg [5] [6] [7] [8] and incidence of diabetes have been reported in many large, prospective studies adjusted for covariates related to cardiometabolic risk. Oral Mg supplementation improves glycemic control in T2DM patients [9] , a condition associated with magnesium depletion [10] . Supplementation resulted in a significant reduction in fasting glucose with an increased insulin sensitivity compared to placebo in a recent, small trial in normomagnesemic, overweight, non-diabetic subjects [11] .
While both GDM and Mg are associated with glycemic outcomes, Mg homeostasis may be modified by GDM. Intracellular Mg concentrations are significantly different in GDM women during their final trimester of pregnancy compared to non-GDM pregnant women [12] . However, no known study has examined the potential effect of GDM in pregnancy on associations between Mg and glycemic variables in women.
We hypothesized that a history of GDM might modify the strength of the associations between Mg and glycemic parameters. Since adolescent offspring born of GDM or gestational impairedglucose-tolerance pregnancies are more insulin resistant than offspring of normoglycemic pregnancies [1] and Mg homeostasis is altered in offspring of diabetic mothers [13] , we further hypothesized that a history of GDM might also modify potential associations between Mg and glycemic variables in offspring 15 years postpartum.
Subjects and methods
In 2005, a comprehensive health evaluation was conducted on a sample of mothers (aged 36-61yrs at time of evaluation) affected by GDM or gestational impaired glucose tolerance during singleton pregnancies between 1989-1990, women with normoglycemic pregnancies delivering during the same time period, and the teenage daughters born of affected and unaffected pregnancies (n = 332). All pregnancies had resulted in term deliveries (37-42 weeks gestation) between 1989 and 1990 at the Royal Victoria Hospital (Montreal, Canada).
GDM and gestational impaired glucose tolerance mothers were stratified by age and socioeconomic categories derived from local census data, and frequency matched to normoglycemic mothers. All women underwent a 50g glucose screen during week 24-28 of gestation, or earlier if assessed as higher risk; those with a glucose value between 7.8 and 11.1 mmol/L went on to a 100g 3-hr oral glucose tolerance test (OGTT). GDM was diagnosed if the glucose screen exceeded 11 mmol/L, or if women had two abnormal OGTT values. Gestational impaired glucose tolerance was diagnosed if one OGTT value was abnormal based on National Diabetes Data Group Criteria [14] . As gestational impaired glucose tolerant subjects were grouped with GDM subjects in the study design, for simplicity, GDM and gestational impaired glucose tolerance are together regarded as GDM. [1] consisting of 189 mother-daughter pairs, plasma and dietary Mg, anthropometric and glycemic variables were available for 166 pairs (n = 332). All daughters had begun to menstruate, and in this subset no daughter had type 1 or type 2 diabetes.
Anthropometric, lifestyle and clinical variable assessment
Weight was assessed by bioelectrical impedance equipped with a scale (Tania Corporation, Arlington Heights, IL, USA), and height was measured to calculate the body mass index (BMI). The BMI for mothers was interpreted according to 1998 designations from the National Heart, Lung, and Blood Institute (a BMI 18.5-24.9 considered normal weight, 25-29.9 considered overweight, ≥30 considered obese). For daughters, BMI was interpreted according to 2000 CDC BMI-for-age growth charts. At risk of overweight was defined as the 85 th -95 th percentile and overweight at>95 th per-centile based on age and gender-specific CDC growth charts. Waist circumference was measured at the midpoint between the bottom of the rib cage and the highest point on the iliac crest. A high waist circumference in mothers was considered to be ≥80 cm based on International Diabetes Federation (IDF) metabolic syndrome criteria [15] . For daughters, an IDF high waist circumference, according to pediatric metabolic syndrome criteria, was considered (≥90 th waist circumference percentile or adult threshold if lower) [16] , and the lower adult threshold was used.
Race was self-reported as were lifestyle variables such as current smoking (yes or no), alcohol consumption and physical activity. Heavy alcohol consumption results in renal Mg wasting [17] , thus, evidence of events of heavy consumption (the individual consumed ≥5 drinks in one sitting on at least one occasion in the past month) was noted. An individual was considered to exercise if she reported engaging in physical activity sufficiently rigorous to induce hard breathing for at least 20 minutes in duration, at least three times per week.
All participants underwent fasting, blood sampling for glucose, insulin, and glycated hemoglobin (HbA 1c ). After a 75g glucose load, venipuncture for serum glucose and insulin values was repeated at 30 and 120min. Glucose was analyzed using the glucose oxidase technique on the BeckmanCoulter LX20 analyzer (Beckman Instruments, Fullerton, CA, USA). Insulin was assessed using an immunometric assay with chemiluminescent detection on an Immulyte immunoanalyzer (Diagnostic Products Corp., Los Angeles, CA, USA). Glycated hemoglobin was measured using an immunoturbidometric method on a Cobas Mira analyzer (Roche, Stockholm, Sweden), with the reagent Roche Unimate 3 hemoglobin A 1c .
For plasma Mg analysis, samples were centrifuged prior to freezing at -80
• C in BD lavender-top vacutainers (containing anticoagulant). 500 l aliquots were withdrawn for shipment to a Nutrasource Diagnostics contractor at the Trace Elements Laboratory of the London Laboratory Services group. At the Trace Elements Laboratory, samples were thawed and diluted with tetramethyl ammonium hydroxide and analyzed for Mg (Finnigan MAT element high resolution inductively coupled plasma mass spectrometer, ICP-MS).
T2DM was confirmed if fasting glucose ≥7 mmol/L, 2 hr glucose ≥11.1 mmol/L, or by the physician's diagnosis. Insulin sensitivity was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR) [18] and the whole body insulin sensitivity index using reduced time points (ISI composite) [19] .
Dietary assessment
Dietary Mg and caloric intake were derived from a 73-item, semiquantitative, self-administered food frequency questionnaire (FFQ), adapted in French and English from the Block National Cancer Institute Health Habits and History Questionnaire. The FFQ was initially tested in 248 Montrealarea adults and validated in a subsample of adults (n = 94) using four, non-consecutive food records [20] . Dietary Mg was adjusted for calories for subsequent multivariate modeling according to Willett & Stampfer's residual approach [21] .
Statistical methods
Arithmetic means and standard deviations were reported for normally distributed lifestyle and demographic characteristics, and plasma Mg means were compared using two-tailed t-tests or ANOVA. Depending on their distributions, Pearson's or Spearman's bivariate correlations between plasma and dietary Mg in mothers and daughters were calculated. For multivariable linear regression analyses, we were interested in identifying the significant covariates of each glycemic parameter, in addition to the influence of plasma and dietary Mg in mothers and daughters. Dependent variables included fasting glucose, fasting insulin, HOMA-IR, HbA 1c , and ISI composite. Their distributions were skewed and log transformed prior to linear regression. For the cross-sectional analyses, four separate multivariate regressions were run for the following independent variables of interest: Collinearity statistics (variance inflation factors, VIFs) were checked in all multivariable models and VIFs did not exceed 1.5 for any variable, in any model. Additional adjustment for exercise, smoking and alcohol consumption did not appreciably alter any of the coefficients for Mg associations with outcome variables (␤ change in Mg<0.02).
To examine whether the associations of plasma and dietary Mg with glycemic dependent variables differed by GDM status or current maternal T2DM status, we entered interaction terms into multivariate adjusted models separately to test their significance. GDM status and maternal T2DM status were binary coded and multiplied by Mg (plasma or dietary) to create the interaction terms. The Wald test was used to assess the significance of multiplicative interaction terms. If the interaction term was significant in the model for a given dependent variable, we conducted subgroup analyses stratified by GDM and/or T2DM for that dependent variable. All p values were two-tailed. All analyses were performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).
Results
Age (32.4 ± 4.5 versus 32.1 ± 5.3 years), parity (0.88 ± 1.07 versus 0.88 ± 1.15), daughters' birthweight (3.36 ± 0.61 versus 3.35 ± 0.49 kg) and pregnancy weight gain (14.3 ± 6.71 versus 13.8 ± 5.04 kg) did not significantly differ between GDM and non-GDM mothers (p>0.05). Mothers with a GDM history had a significantly greater mean pre-pregnancy BMI (25.5 ± 5.0 versus 23.1 ± 3.81 kg/m 2 ; p<0.01) and earlier gestational age at delivery (271 ± 13.9 versus 274 ± 11.2 days; p<0.05) than non-GDM mothers. No other differences in obstetric or neonatal characteristics were observed.
Plasma Mg concentrations did not differ between mothers taking proton pump inhibitors, thiazide or loop diuretics, or aminoglycosides (plasma Mg: 0.96 ± 0.12 mmol/L; n = 8) and women not taking these medications (Mg: 0.94 ± 0.12 mmol/L; n = 158) (t-test, p = 0.62). Twenty-eight women (17%) took a multivitamin, and 14 (8%) indicated explicit use of Mg supplements, but plasma Mg concentrations did not differ among those who used supplements (0.94 ± 0.11 mmol/L) and those who did not (0.93 ± 0.12 mmol/L; t-test, p = 0.63); results did not differ materially when GDM or T2DM status were adjusted for.
Plasma Mg concentrations were significantly associated with race, GDM history, and current T2DM status in mothers. Caucasian mothers, non-GDM mothers, and mothers without current T2DM were more likely to have higher plasma Mg concentrations (table 1) . Plasma Mg in GDM mothers was lower in comparison to non-GDM mothers after adjustment for current T2DM, race and BMI (0.90 ± 0.01 versus 0.96 ± 0.01 mmol/L; p = 0.002). Among mothers without current T2DM, unadjusted plasma Mg concentrations were 0.92 ± 0.10 mmol/L for GDM mothers and 0.97 ± 0.12 mmol/L for control mothers (p = 0.02). Total dietary Mg intake did not differ significantly between GDM (336.7 ± 152.0mg) and non-GDM mothers (303.9 ± 125.0mg) (p = 0.19), nor did calorie-adjusted Mg intake (325.2 ± 67.4mg versus 312.8 ± 65.9mg; p = 0.24).
Six daughters took a multivitamin and one took Mg supplements, but plasma Mg concentrations did not differ between supplement users (0.84 ± 0.04 mmol/L) and non-users (0.90 ± 0.09 mmol/L; t-test, p = 0.082). GDM-born daughters had higher plasma Mg concentrations than nonGDM daughters (0.92 ± 0.11 versus 0.88 ± 0.05 mmol/L; p = 0.002). Total dietary intake did not differ significantly between GDMborn daughters (264.3 ± 120.9mg) and non-GDM daughters (247.5 ± 99.9mg) (p = 0.33), nor did calorie-adjusted Mg intake (259.2 ± 66.7mg versus 251.5 ± 54.3mg; p = 0.41).
Plasma and dietary Mg were not significantly correlated in mothers (spearman's rho = -0.110; p = 0.16) nor in daughters (-0.033; p = 0.67).
Plasma Mg, dietary Mg and glycemic parameters in mothers
Mothers' GDM status 15-yrs prior, current BMI, and T2DM status were significantly associated with glycemic variables ( 
Plasma Mg, dietary Mg and glycemic parameters in 15-year-old daughters
Daughters' BMI was significantly associated with fasting insulin, HOMA IR, and ISI composite; neither their mothers' GDM status during the pregnancy nor current maternal T2DM status was significantly associated with any of daughters' glycemic variables. Daughters' plasma Mg was inversely associated with HbA 1c in adjusted models (␤ ± SE, p for plasma Mg: -0.10 ± 0.05; p = 0.05) (table 3). A history of GDM in mothers modified the association between daughters' plasma Mg and fasting glucose; fasting glucose estimates per 1 unit plasma Mg increase were -0.03 ± 0.01 (p = 0.06) for GDM-born daughters and 0.02 ± 0.01 (p = 0.13) for non-GDM daughters. The daughters' dietary Mg was significantly inversely associated with fasting glucose in adjusted models (␤ ± SE, p for dietary Mg: -0.02 ± 0.01; p = 0.03). No significant interactions with dietary Mg were detected (table 3).
Discussion
In this cross-sectional study involving 332 mothers and daughters, we found that mothers with a history of GDM were more likely to have lower plasma Mg concentrations 15 years later in comparison to mothers without a GDM history. Plasma Mg was significantly associated with glycemic parameters (fasting insulin, HOMA IR, ISI composite), only in mothers with a GDM history. Plasma and dietary Mg were significantly and inversely associated with HbA 1c and fasting glucose respectively, in the total population of healthy, nondiabetic, 15-year-old girls. Mothers' GDM history modified the association between daughters' plasma Mg and fasting glucose.
The novel finding that plasma Mg concentrations assessed at 15-years post-partum were significantly lower in mothers with a GDM history in comparison to mothers without, independent of current maternal diabetic status, race, BMI, and dietary Mg intake, cannot be entirely explained. While glycosuria can result in renal Mg wasting secondary to osmotic diuresis [22] when blood glucose concentrations exceed ∼11 mmol/L, there was no significant difference between the number of GDM mothers reaching a blood glucose value of 11 mmol/L thirty minutes into the OGTT at followup and non-GDM mothers ( 2 test: p = 0.22).
Variables related to glycemic control in GDM history mothers without T2DM were no worse than non-GDM mothers without T2DM (p = 0.10 for mean difference in glucose 120; p = 0.33 for mean difference in HbA 1c ); results were similar when comparing the whole population of mothers. Gestational diabetic pregnancy itself may be associated with changes in Mg homeostasis, contributing to other potential mechanisms leading to altered Mg biomarkers among women with a GDM history. During the third trimester of pregnancy, intracellular free Mg concentrations in GDM women differ from non-GDM pregnant women [12, 23] , but this difference is not reflected in total plasma Mg concentrations [23] , nor is it expected that altered Mg biomarkers associated with pregnancy should persist over time. However, among mothers without T2DM, insulin sensitivity was significantly worse among GDM in comparison to non-GDM mothers (p = 0.05 for mean difference in ISI composite; p = 0.01 for mean difference in HOMA IR), and insulin sensitivity was associated with higher plasma Mg concentrations in GDM mothers. Fractional excretion of Mg has been shown to increase as a function of insulin concentration after adjustment for age, sex and BMI among non-diabetics [24] , and may be the most likely explanation for the observed difference in plasma Mg between GDM and non-GDM mothers.
To our knowledge, the finding that Mg concentrations are significantly higher in offspring who developed during gestational diabetic or glucosetolerance-impaired pregnancies in comparison to offspring born of normal pregnancies has never been reported in humans. Although this finding could be caused by chance, tubular reabsorptive mechanisms for Mg are increased markedly in rat offspring born of diabetic pregnancies in comparison to rats born of normal pregnancies [25] , and Mg excretion is reduced in children and adolescents born of mothers with diabetes [13] . GDM-born 15-year-old daughters currently at the ≥75 th percentile of insulin resistance (HOMA IR) among all daughters, do not have significantly different plasma Mg concentrations than the total study population of non-GDM daughters (0.89 ± 0.09 mmol/L versus 0.88 ± 0.05 mmol/L; p = 0.47), but the mean plasma Mg concentration in GDM-born daughters currently at ≤25 th percentile HOMA IR is 0.94 ± 0.19 mmol/L. We speculate that potential in utero programming of A history of GDM may be an important effect modifier of associations between Mg status and glycemic variables in affected mothers and affected offspring. Nonetheless, even if the finding that a GDM history interacts with Mg-glycemic outcomes is replicated in other studies, the low prevalence of GDM in general populations suggest that overall model estimates for plasma Mg and glycemic parameters would not be affected for large epidemiological cohorts. Since a lack of baseline Mg concentrations is a limitation of our study design, future studies elucidating the temporal relation between the observed differences between plasma Mg concentrations in GDM and non-GDM mothers and daughters are required. Other limitations include lack of data on GDM status in subsequent pregnancies and the possibility that a GDM history could be a proxy for unmeasured glycemic risk factors or other underlying factors in affected mothers and daughters. Plasma Mg is associated with blood concentrations of other nutrients and similarly, dietary Mg is strongly correlated with dietary fiber, potassium, and folic acid and therefore the effect of Mg per se cannot be entirely separated from other nutrients or dietary patterns in observational studies. Another limitation of this study is use of plasma Mg instead of ionized Mg as a biomarker [26] ; free intracellular Mg is the fraction regulating enzyme pathways [27] . Since extracellular Mg concentrations are under tight homeostatic regulation in the human body, normal levels of plasma Mg are within a narrow range and may not be a sensitive marker in reflecting mild Mg inadequacy or the intracellular Mg pool. However, plasma Mg correlates well with intracellular free Mg as measured by nuclear magnetic resonance spectroscopy [28] . Grouping of GDM with gestational impaired glucose itolerance cases is also a limitation, but segregating GDM mothers and daughters from gestational impaired glucose intolerant mothers and daughters would result in inappropriately small sample sizes for our analyses.
GDM predisposes women to increased risk of adverse glycemic variables, which may represent potential pathophysiological mechanisms for the eventual development of T2DM. It remains to be elucidated if Mg biomarkers and homeostasis are altered prior to, during and/or as a result of gestational diabetic pregnancies in humans, and whether or not plasma Mg is related to longitudinal changes in glycemic variables. Clinical trials are warranted to unravel possible causal effects of Mg supplementation on glycemic status and T2DM.
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